Superdrol 10mg/tab 100 Tabletten by Dragon-Pharma

Usage

1. Confirm your baseline liver enzyme values (ALT, AST) via blood panel before starting — methyldrostanolone's 17α-methyl group imposes hepatic stress proportional to dose and duration, making a pre-cycle reference value essential.
2. Take each 10 mg tablet orally with a moderate-fat meal to support absorption; the 17α-alkylated structure provides inherent bioavailability but consistent co-administration with dietary fat reduces GI variability.
3. Split your daily dose across two administrations (e.g., morning and early afternoon) to leverage the ~6–8 h effective half-life and maintain more consistent androgen receptor occupancy throughout waking hours.
4. Do not co-administer with other 17α-alkylated oral anabolics during the same cycle — stacking two hepatotoxic substrates compounds CYP enzyme load beyond what the receptor-binding benefit justifies.
5. Monitor subjective markers of androgen receptor over-stimulation (blood pressure elevation, scalp sensitivity, aggressive mood shifts) as early indicators that dose requires downward adjustment.
6. Begin PCT (SERM-based protocol — tamoxifen or clomiphene) within 24–48 hours of the final tablet, since methyldrostanolone's short half-life means endogenous HPG axis suppression persists briefly into the post-cycle window.

Warnings

Frequently asked questions

How does methyldrostanolone bind to the androgen receptor compared to testosterone?

Methyldrostanolone binds the androgen receptor with greater molar affinity than testosterone, as demonstrated in competitive in-vitro displacement assays using tritiated DHT. Its 2α-methyl group modifies the ligand-binding domain interaction, producing stronger AR occupancy per molecule. This elevated receptor affinity is the primary mechanistic basis for its pronounced anabolic and androgenic effects at relatively low per-day doses.

Why doesn't Superdrol (methyldrostanolone) convert to estrogen in the body?

Methyldrostanolone cannot be aromatized because it belongs to the DHT-derivative structural class, and CYP19A1 (aromatase) requires a non-methylated A-ring configuration at C2 to catalyze conversion to estrogen. Since methyldrostanolone carries a 2α-methyl substitution on its DHT backbone, the enzyme cannot bind the substrate correctly, leaving the compound without an estrogenic conversion pathway.

What does the chemical lineage from dihydrotestosterone mean for Superdrol's anabolic effects?

DHT-derived compounds, including methyldrostanolone, are already in a fully 5α-reduced state, meaning tissue-level 5α-reductase cannot reduce them further. This makes their androgenic potency consistent across androgen-sensitive tissues without the amplification seen with testosterone. The lineage also means no progestogenic activity, distinguishing methyldrostanolone's receptor profile from 19-nor compounds like nandrolone.

Can Dragon Pharma Superdrol 10 mg tablets be split for lower doses?

Dragon Pharma's 10 mg tablets are manufactured as uniform compressed units; physical splitting is possible with a tablet cutter but is not recommended as the primary dosing method, since homogeneity across the split halves is not analytically guaranteed post-production. For precise sub-10 mg dosing, selecting a formulation at the target dose is preferable.

How are the 100-tablet units of Dragon Pharma Superdrol packaged for integrity and discretion?

Dragon Pharma supplies Superdrol in 100-tablet blister or sealed bottle format depending on the production run, with tamper-evident outer packaging. The compact tablet format simplifies daily dosing administration without the need for reconstitution or injection equipment, supporting straightforward integration into structured oral-only or stacked cycle protocols. (2) angle_used

Manufacturer

Dragon Pharma's tablet manufacturing division operates on a principle that was established at the company's founding and has not been modified as its catalogue expanded: every active ingredient declared on a label must be backed by quantitative measurement, not formulation assumption. For Superdrol 10 mg specifically, this translates into a two-stage analytical gate — raw methyldrostanolone API undergoes identity confirmation before it enters the tableting process, and a statistically representative sample from each finished 100-tablet batch is submitted to HPLC quantification against a certified reference compound, with the resulting concentration data archived in batch-level records. Dragon Pharma's decision to enter the oral anabolic market was shaped by a gap it identified early: products in this category were frequently underdosed or inconsistently blended because there was no external pressure on underground manufacturers to verify finished-tablet homogeneity. By building internal analytical capacity and documenting it at the batch level, Dragon Pharma positioned its oral line — including high-potency compounds like methyldrostanolone — as analytically accountable in a way that distinguishes it from production operations that rely solely on formulation arithmetic.